Antibody development techniques are very time consuming and labor intensive. Typically monoclonal antibodies are produced by fusing primed mammalian cells with myeloma cells, creating immortal hybrid cell lines that can generate the desired monoclonal antibody in virtually unlimited quantities; this process can take from four months to a year or more.

Custom-Designed Immunologics, has developed  the Fast-MAb™ antibody development platform, which is a high-throughput anti-human monoclonal antibody production platform that shortens development time to six weeks. The platform also incorporates a novel, proprietary antibody characterization technique that raises the bar of anti-human antibody characterization. The platform is capable of parallel production of monoclonal antibodies against different proteins, allowing for a high-throughput approach to large sets of target antigens.